Ozempic 1mg

Ozempic 1 mg is an intermediate dose of semaglutide, a once-weekly injectable prescription medication manufactured by Novo Nordisk. It is primarily approved to improve blood sugar control in adults with type 2 diabetes and to reduce the risk of major cardiovascular events like heart attacks or strokes. While not officially FDA-approved as a weight loss drug, it is frequently prescribed off-label because it suppresses appetite and delays stomach emptying.